A Randomized Controlled Study on the Application of LEARNS Health Education Combined with Intelligent Follow-up Management in Secondary Prevention of Ischemic Stroke and Its Impact on Patient Compliance and Neurological Function

一项关于应用 LEARNS 健康教育联合智能随访管理在缺血性卒中二级预防中的作用及其对患者依从性和神经功能影响的随机对照研究

阅读:2

Abstract

OBJECTIVE: This randomized controlled study aimed to evaluate the effectiveness of LEARNS health education combined with intelligent follow-up management in the secondary prevention of ischemic stroke (IS), focusing on patient compliance and neurological function outcomes. The LEARNS model is a structured patient education framework encompassing Listen, Establish, Adopt, Reinforce, Name, and Strengthen, aiming to support individualized and interactive patient learning. METHODS: A total of 120 first-episode IS patients admitted to the Neurology Department of our hospital from April to June 2024 were enrolled and randomly assigned to either a control group (n = 60), receiving conventional health education plus intelligent follow-up, or an observation group (n = 60), receiving LEARNS health education combined with intelligent follow-up management. Patient outcomes were assessed using the General Medication Adherence Scale (GMAS), secondary prevention control measures (including blood glucose, blood pressure, lipid control, smoking/alcohol cessation, obesity control, and exercise adherence), the Barthel Index (BI) for neurological function, and ischemic stroke recurrence. Evaluations were conducted at discharge and at all follow-up time points within six months post-discharge. RESULTS: Compared to the control group, the observation group showed significantly higher medication adherence rates, better control in all secondary prevention measures, and higher neurological function recovery rates at all follow-up time points (P < 0.05). Additionally, the 6-month recurrence rate was significantly lower in the observation group (1.67%) than in the control group (13.33%) (P < 0.05). CONCLUSION: LEARNS health education combined with intelligent follow-up management effectively enhances patient compliance, improves secondary prevention outcomes, supports neurological recovery, and reduces recurrence risk in patients with ischemic stroke.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。